3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
40
Leukemia, Myeloid, Chronic-Phase
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia
5
Blast Crisis
5
Neoplasm Metastasis
3
Melanoma
3
Leukemia, Myeloid, Acute
3
Gastrointestinal Stromal Tumors
3
Synovitis, Pigmented Villonodular
2
Recurrence
2
Leukemia, Myeloid, Accelerated Phase
2
Substance Withdrawal Syndrome
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Neurofibromatoses
1
Neurofibroma, Plexiform
1
Neurofibroma
1
Neoplasms
1
Neoplasm, Residual
1
Mucosal Lentiginous Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Non-Hodgkin
1
Head and Neck Neoplasms
1
Glioma
1
Giant Cell Tumor of Tendon Sheath
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Chordoma
1
Carcinoma, Squamous Cell
1
Interventions
Oxaliplatin
112
Fluorouracil
104
Leucovorin
91
Irinotecan
91
Capecitabine
59
Bevacizumab
58
Cetuximab
46
Folfox protocol
28
Colonoscopy
24
Panitumumab
19
Chemotherapy, Adjuvant
19
Blood Specimen Collection
19
Drug Therapy
18
Nivolumab
17
Magnetic Resonance Spectroscopy
17
Radiotherapy
16
Exercise
16
Early Intervention, Educational
16
Surveys and Questionnaires
15
Laparoscopy
15
Surgical Procedures, Operative
13
Floxuridine
13
Biopsy
13
trifluridine tipiracil drug combination
12
pembrolizumab
12
XELOX
12
Neoadjuvant Therapy
11
Methods
11
Immunohistochemistry
11
Celecoxib
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Colonic Neoplasms
×
nilotinib
×
Clear all
NCT02774512
2017-10-06
ZAK-0
Institut Bergonié
Phase EARLY_PHASE1
Withdrawn